CBD

FDA Objects To CBD As Diet Supplement, Extending Uncertainty

The FDA objected to an application from Charlotte’s Web Holdings Inc.

The U.S. Food and Drug Administration objected to an application from Charlotte’s Web Holdings Inc. for a CBD product to be sold as a dietary ingredient, leaving a cloud of uncertainty over the booming industry for the cannabis-derived substance.

The company’s bid to sell its full-spectrum hemp extract with CBD as a dietary supplement won’t be considered because of the FDA’s own prior decision to treat CBD as a drug, according to a letter posted on the agency’s website Wednesday. This shouldn’t disrupt the business of Charlotte’s Web or prevent other companies from continuing to sell such products, which already exist in a gray area without the agency’s oversight.

To Read The Rest Of This Article On Bloomberg, Click Here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

CHAMPS Smoke Shop Report, or ‘CSS’, online source for the updates and innovations on the smoke shop scene. News and information are geared strictly to accessories retail channels, with distribution limited to retailers that Smoke Shop products and wholesalers.

Newsletter

Stay informed with the most up-to-date industry news to help you grow your business: subscribe to our newsletter below!


  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag(‘js’, new Date());gtag(‘config’, ‘UA-101727731-3’);

Copyright © 2021 CHAMPS Smoke Shop Report. Terms & Conditions | Privacy Policy

To Top